<SEC-DOCUMENT>0000950103-25-015248.txt : 20251125
<SEC-HEADER>0000950103-25-015248.hdr.sgml : 20251125
<ACCEPTANCE-DATETIME>20251125161058
ACCESSION NUMBER:		0000950103-25-015248
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20251125
DATE AS OF CHANGE:		20251125

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251521305

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp237893_424b2-8080wfpps.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #DE1A1E"><FONT STYLE="font-size: 9pt"><B>The
information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement and the accompanying
prospectus, prospectus supplement and product supplement do not constitute an offer to sell the securities and we are not soliciting
an offer to buy the securities in any state where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 9pt; color: #DE1A1E">Subject
to Completion. Dated </FONT><FONT STYLE="font-size: 9pt; color: #EC1C29">November 25, 2025</FONT><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 53%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">PRICING SUPPLEMENT
    dated December&nbsp;&nbsp; , 2025</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(To the Prospectus
    dated May 15, 2025,</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">the Prospectus
    Supplement dated May 15, 2025 and</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">the Product Supplement
    No. WF-1 dated May 20, 2025)</FONT></P></TD>
    <TD STYLE="width: 47%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Filed Pursuant
    to Rule 424(b)(2)</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Registration Statement
    No. 333-287303</FONT></P></TD></TR>
  <TR>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="barclays PLC logo" STYLE="height: 42px; width: 179px"></FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left; color: #BB0826">Global Medium-Term Notes, Series
A</P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="color: #BB0826; font: bold 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent
Fixed Return and Contingent Downside</P>
    <P STYLE="color: #BB0826; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Principal at Risk Securities
Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December
30, 2026</P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -13.7pt; color: white"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Linked
to the lowest performing of the common stock of Advanced Micro Devices, Inc. and the common stock of NVIDIA Corporation (each referred
to as an &ldquo;<U>Underlying Stock</U>&rdquo;)</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Unlike
ordinary debt securities, the securities do not pay interest or repay a fixed amount of principal at maturity. Instead, the securities
provide for a maturity payment amount that may be greater than or less than the principal amount of the securities, depending on the
performance of the lowest performing Underlying Stock. The lowest performing Underlying Stock is the Underlying Stock that has the lowest
stock return (i.e., the lowest percentage change from its starting price to its ending price). The maturity payment amount will reflect
the following terms:</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.5in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">&nbsp;&nbsp;If
the stock closing price of the lowest performing Underlying Stock increases, remains flat or decreases, but the decrease is not more
than 40%, you will receive the principal amount plus a contingent fixed return of at least 21.00% (to be determined on the pricing date)
of the principal amount.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.5in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;If
the <FONT STYLE="color: white">stock closing </FONT>price of the lowest performing Underlying Stock decreases by more than 40%, you will
have full downside exposure to the decrease in the <FONT STYLE="color: white">stock closing </FONT>price of that Underlying Stock, and
you will lose more than 40%, and possibly all, of the principal amount of your securities.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Investors
may lose more than 40%, and possibly all, of the principal amount.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Any
positive return on the securities at maturity will be limited to the contingent fixed return, even if the ending price of the lowest
performing Underlying Stock significantly exceeds its starting price; you will not participate in any appreciation of any Underlying
Stock.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Your
return on the securities will depend <B>solely</B> on the performance of the lowest performing Underlying Stock. You will not benefit
in any way from the performance of the better performing Underlying Stock. Therefore, you will be adversely affected if <B>either Underlying
Stock </B>performs poorly, even if the other Underlying Stock performs favorably.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Any
payment on the securities, including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed
by any third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in
Power (as described on page PPS-6 of this pricing supplement) by the relevant U.K. resolution authority, you might not receive any amounts
owed to you under the securities. See &ldquo;Selected Risk Considerations&rdquo; and &ldquo;Consent to U.K. Bail-in Power&rdquo; in this
pricing supplement and &ldquo;Risk Factors&rdquo; in the accompanying prospectus supplement.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;No
periodic interest payments or dividends</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;No
exchange listing; designed to be held to maturity</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">See &ldquo;Additional Information about the
Issuer and the Securities&rdquo; on page PPS-4 of this pricing supplement. The securities will have the terms specified in the prospectus
dated May 15, 2025, the prospectus supplement dated May 15, 2025 and the product supplement no. WF-1 dated May 20, 2025, as supplemented
or superseded by this pricing supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities have complex features and
investing in the securities involves risks not associated with an investment in conventional debt securities. See &ldquo;Selected Risk
Considerations&rdquo; on page PPS-10 herein, &ldquo;Risk Factors&rdquo; beginning on page PS-3 of the product supplement and &ldquo;Risk
Factors&rdquo; beginning on page S-9 of the prospectus supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities constitute our unsecured and
unsubordinated obligations. The securities are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial
Services Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit
insurance agency of the United States, the United Kingdom or any other jurisdiction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Neither the U.S. Securities and Exchange
Commission (the &ldquo;<U>SEC</U>&rdquo;) nor any state securities commission has approved or disapproved of these securities or determined
that this pricing supplement is truthful or complete. Any representation to the contrary is a criminal offense.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority. See &ldquo;Consent to U.K. Bail-in Power&rdquo; on page PPS-6 of this pricing supplement.</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 21%; text-align: justify; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Original Offering Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 27%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agent Discount<SUP>(2), (3)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceeds to Barclays Bank PLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$23.25</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$976.75</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-size: 9pt; background-color: white"><SUP>(1)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt; background-color: white">Our
                                            estimated value of the securities on the pricing date, based on our internal pricing models,
                                            is expected to be between $904.10 and $954.10 per security. The estimated value is expected
                                            to be less than the original offering price of the securities. See &ldquo;Additional Information
                                            Regarding Our Estimated Value of the Securities&rdquo; on page PPS-5 of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-size: 9pt; background-color: white"><SUP>(2)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt; background-color: white">Wells
                                            Fargo Securities, LLC (&ldquo;WFS&rdquo;) and Barclays Capital Inc. are the agents for the
                                            distribution of the securities and are acting as principal. The agent will receive an underwriting
                                            discount of up to $23.25 per security. Barclays Capital Inc. will sell the securities to
                                            WFS at the original offering price of the securities less a concession not in excess of $23.25
                                            per security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;WFA&rdquo;)
                                            (the trade name of the retail brokerage business of WFS&rsquo;s affiliates, Wells Fargo Clearing
                                            Services, LLC and Wells Fargo Advisors Financial Network, LLC), with a selling concession
                                            of $17.50 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per
                                            security of the agent&rsquo;s discount to WFA as a distribution expense fee for each security
                                            sold by WFA. See &ldquo;Terms of the Securities&mdash;Supplemental Plan of Distribution&rdquo;
                                            in this pricing supplement for further information.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-size: 9pt; background-color: white"><SUP>(3)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt; background-color: white">In
                                            respect of certain securities sold in this offering, Barclays Capital Inc. may pay a fee
                                            of up to $1.00 per security to selected securities dealers in consideration for marketing
                                            and other services in connection with the distribution of the securities to other securities
                                            dealers.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify; font-size: 12pt; font-weight: bold">Wells Fargo Securities</TD>
    <TD STYLE="width: 50%; text-align: right; font-size: 12pt; font-weight: bold">Barclays Capital Inc.</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="padding: 4pt; color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: center; background-color: #4F81BD"><FONT STYLE="font-size: 12pt">Terms
of the Securities</FONT></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 20%; border: white 1.5pt solid; background-color: #E0E3E2; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issuer:</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 80%; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="border-bottom: rgb(224,227,226) 1pt solid">
    <TD STYLE="border-right: White 1.5pt solid; border-left: White 1.5pt solid; background-color: #E0E3E2; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The common stock of Advanced Micro Devices, Inc. (the &ldquo;<U>AMD Stock</U>&rdquo;) and the common stock of NVIDIA Corporation (the &ldquo;<U>NVDA Stock</U>&rdquo;) (each referred to as an &ldquo;<U>Underlying Stock</U>,&rdquo; and collectively as the &ldquo;<U>Underlying Stocks</U>&rdquo;). We refer to the issuers of the Market Measures as the &ldquo;<U>Underlying Stock Issuers</U>.&rdquo;</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD ROWSPAN="3" STYLE="border-bottom: rgb(224,227,226) medium solid; border-top: rgb(224,227,226) medium solid; border-right: Black 1pt solid; width: 20%; background-color: rgb(224,227,226)"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market Measures<SUP>1</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market Measure</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Bloomberg Ticker Symbol</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Starting Price<SUP>(a)</SUP></B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Threshold Price<SUP>(b)</SUP></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">AMD Stock</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">AMD UW&lt;Equity&gt;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">NVDA Stock</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">NVDA UW&lt;Equity&gt;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="border-top: rgb(224,227,226) 1pt solid">
    <TD STYLE="border-right: White 1.5pt solid; width: 20%; border-left: White 1.5pt solid; background-color: #E0E3E2">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 80%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt"><SUP>(a)</SUP>
    With respect to each Underlying Stock, the stock closing price of that Underlying Stock on the pricing date</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt"><SUP>(b)</SUP>
    With respect to each Underlying Stock, 60% of its starting price</FONT></P></TD></TR>
  <TR>
    <TD STYLE="border: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">December 17, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">December 22, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Calculation Day<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">December 24, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stated Maturity Date<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">December 30, 2026</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Principal Amount:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 per security. References in this pricing supplement to a &ldquo;<U>security</U>&rdquo; are to a security with a principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maturity Payment Amount: </B></FONT></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will be
entitled to receive a cash payment per security in U.S. dollars equal to the maturity payment amount. The &ldquo;<U>maturity payment
amount</U>&rdquo; per security will equal:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;if
the ending price of the lowest performing Underlying Stock is greater than or equal to its threshold price: </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">$1,000 + the contingent fixed return; or</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;if
the ending price of the lowest performing Underlying Stock is less than its threshold price: </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">$1,000 + ($1,000 &times; stock return of the lowest
performing Underlying Stock)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the ending price of the lowest performing
Underlying Stock is less than its threshold price, you will lose more than 40%, and possibly all, of the principal amount of your securities
at maturity. Any payment on the securities, including any repayment of principal, is subject to the creditworthiness of Barclays Bank
PLC and is not guaranteed by any third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the
exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority, you might not receive any amounts owed to you under the
securities.</B></P></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Lowest Performing Underlying Stock:</B></FONT></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The &ldquo;<U>lowest performing Underlying Stock</U>&rdquo; will
be the Underlying Stock with the lowest stock return.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Contingent Fixed Return:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>contingent fixed return</U>&rdquo; will be determined on the pricing date and will be at least 21.00% of the principal amount (at least $210.00 per security). The contingent fixed return is payable only if the ending price of the lowest performing Underlying Stock is greater than or equal to its threshold price.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stock Return:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &ldquo;<U>stock return</U>&rdquo; with
respect to an Underlying Stock is the percentage change from its starting price to its ending price, measured as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>ending price &ndash; starting price</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">starting price</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ending Price:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>ending price</U>&rdquo; of an Underlying Stock will be its stock closing price on the calculation day.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 20%; border: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stock Closing Price<SUP>1</SUP>: </B></FONT></TD>
    <TD STYLE="width: 80%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">With respect to each Underlying Stock, &ldquo;<U>stock closing price</U>&rdquo; has the meaning set forth under &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Certain Definitions&rdquo; in the product supplement. The stock closing price of each Underlying Stock is subject to adjustment through the adjustment factor as described in the product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Additional Terms:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Terms used in this pricing supplement, but not defined herein, will have the meanings ascribed to them in the product supplement, <I>provided</I> that terms used in this pricing supplement, but not defined herein or in the product supplement, will have the meanings ascribed to them in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Tax Considerations:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For a discussion of the tax considerations relating to ownership and disposition of the securities, see &ldquo;Tax Considerations.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Denominations:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">06746ETK1 / US06746ETK19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Supplemental Plan of Distribution:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wells Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;)
and Barclays Capital Inc. will act as agents for the securities. The agent will receive an underwriting discount of up to $23.25 per
security. Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a concession not
in excess of $23.25 per security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;) (the trade
name of the retail brokerage business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial
Network, LLC), with a selling concession of $17.50 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per
security of the agent&rsquo;s discount to WFA as a distribution expense fee for each security sold by WFA.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in respect of certain securities
sold in this offering, Barclays may pay a fee of up to $1.00 per security to selected securities dealers in consideration for marketing
and other services in connection with the distribution of the securities to other securities dealers.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC or its affiliate will enter
into swap agreements or related hedge transactions with one of its other affiliates or unaffiliated counterparties in connection with
the sale of the securities. If WFS, Barclays Capital Inc. or an affiliate of either agent participating as a dealer in the distribution
of the securities conducts hedging activities for Barclays Bank PLC in connection with the securities, such agent or participating dealer
will expect to realize a projected profit from such hedging activities, and this projected profit will be in addition to any discount,
concession or fee received in connection with the sale of the securities to you. This additional projected profit may create a further
incentive for the agents or participating dealers to sell the securities to you.</P></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt"><SUP></SUP></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt"><SUP>1</SUP> In
the case of certain corporate events related to an Underlying Stock, the calculation agent may adjust the adjustment factor of that Underlying
Stock if the calculation agent determines that the event has a diluting or concentrative effect on the theoretical value of the shares
of that Underlying Stock. Upon the occurrence of certain reorganization events with respect to an Underlying Stock, the calculation agent
will make adjustments to reflect the amount and type of property deliverable for one share of that Underlying Stock as a result of that
reorganization event. An Underlying Stock may be replaced with another stock selected by the calculation agent upon the occurrence of
certain replacement stock events. For more information, see &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities
Linked to an Underlying Stock&mdash;Adjustment Events&rdquo; in the accompanying product supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt"><SUP>2</SUP> If
the calculation day is not a trading day with respect to either Underlying Stock, the calculation day for each Underlying Stock will
be postponed to the next succeeding day that is a trading day with respect to each Underlying Stock. The calculation day will also be
postponed for either Underlying Stock if a market disruption event occurs with respect to that Underlying Stock on the calculation day
as described under &ldquo;General Terms of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Calculation
Day&mdash;Securities Linked to Multiple Market Measures&rdquo; in the accompanying product supplement. In addition, the stated maturity
date will be postponed if that day is not a business day or if the calculation day is postponed as described under &ldquo;General Terms
of the Securities&mdash;Payment Dates&rdquo; in the accompanying product supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-size: 12pt">Additional
Information about the Issuer and the Securities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this pricing supplement together
with the prospectus dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term
Notes, Series A, of which these securities are a part and the product supplement no. WF-1 dated May 20, 2025. This pricing supplement,
together with the documents listed below, contains the terms of the securities and supersedes all prior or contemporaneous oral statements
as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for
implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things,
the matters set forth under &ldquo;Risk Factors&rdquo; in the prospectus supplement and &ldquo;Selected Risk Considerations&rdquo; in
this pricing supplement, as the securities involve risks not associated with conventional debt securities. We urge you to consult your
investment, legal, tax, accounting and other advisors before you invest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the information or terms in this
pricing supplement are different from or inconsistent with the information or terms in the prospectus, prospectus supplement or product
supplement, the information and terms in this pricing supplement will control. To the extent the information or terms in the product supplement
are different from or inconsistent with the information or terms in the prospectus or prospectus supplement, the information and terms
in the product supplement will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access these documents on the SEC website
at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm" STYLE="color: Blue; text-decoration: underline">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus Supplement dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm" STYLE="color: Blue; text-decoration: underline">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product Supplement No. WF-1 dated May 20, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm" STYLE="color: Blue; text-decoration: underline">http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our SEC file number is 1-10257. As used in this
pricing supplement, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank PLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-size: 12pt">Additional
Information Regarding Our Estimated Value of the Securities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The final terms for the securities will be determined
on the date the securities are initially priced for sale to the public (the &ldquo;<U>pricing date</U>&rdquo;) based on prevailing market
conditions on or prior to the pricing date and will be communicated to investors orally and/or in a final pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our internal pricing models take into account
a number of variables and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility,
interest rates and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on
variables, such as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels
at which our benchmark debt securities trade in the secondary market. Our estimated value on the pricing date is based on our internal
funding rates. Our estimated value of the securities might be lower if such valuation were based on the levels at which our benchmark
debt securities trade in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value of the securities on the pricing
date is expected to be less than the original offering price of the securities. The difference between the original offering price of
the securities and our estimated value of the securities is expected to result from several factors, including any sales commissions expected
to be paid to Barclays Capital Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to
be allowed or paid to non-affiliated intermediaries, the estimated profit that we or any of our affiliates expect to earn in connection
with structuring the securities, the estimated cost that we may incur in hedging our obligations under the securities, and estimated development
and other costs that we may incur in connection with the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value on the pricing date is not
a prediction of the price at which the securities may trade in the secondary market, nor will it be the price at which Barclays Capital
Inc. may buy or sell the securities in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or
another affiliate of ours intends to offer to purchase the securities in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming that all relevant factors remain constant
after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market, if
any, and the value that we may initially use for customer account statements, if we provide any customer account statements at all, may
exceed our estimated value on the pricing date for a temporary period expected to be approximately three months after the initial issue
date of the securities because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost
of hedging our obligations under the securities and other costs in connection with the securities that we will no longer expect to incur
over the term of the securities. We made such discretionary election and determined this temporary reimbursement period on the basis of
a number of factors, which may include the tenor of the securities and/or any agreement we may have with the distributors of the securities.
The amount of our estimated costs that we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement
period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the initial issue
date of the securities based on changes in market conditions and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We urge you to read the &ldquo;Selected Risk
Considerations&rdquo; beginning on page PPS-10 of this pricing supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You may revoke your offer to purchase the securities
at any time prior to the pricing date. We reserve the right to change the terms of, or reject any offer to purchase, the securities prior
to their pricing date. In the event of any changes to the terms of the securities, we will notify you and you will be asked to accept
such changes in connection with your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-size: 12pt">Consent
to U.K. Bail-in Power</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between us and any holder or beneficial owner of
the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner
of the securities acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the U.K. Banking Act 2009, as amended, the
relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority
is satisfied that the resolution conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely
to fail to satisfy the Financial Services and Markets Act 2000 (the &ldquo;<U>FSMA</U>&rdquo;) threshold conditions for authorization
to carry on certain regulated activities (within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that
is a European Economic Area (&ldquo;<U>EEA</U>&rdquo;) or third country institution or investment firm, that the relevant EEA or third
country relevant authority is satisfied that the resolution conditions are met in respect of that entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.K. Bail-in Power includes any write-down,
conversion, transfer, modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities; (ii) the conversion of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities into shares or other securities or other obligations
of Barclays Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the securities of such shares,
securities or obligations); (iii) the cancellation of the securities and/or (iv) the amendment or alteration of the maturity of the securities,
or the amendment of the amount of interest or any other amounts due on the securities, or the dates on which interest or any other amounts
become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power may be exercised by means of a variation
of the terms of the securities solely to give effect to the exercise by the relevant U.K. resolution authority of such U.K. Bail-in Power.
Each holder and beneficial owner of the securities further acknowledges and agrees that the rights of the holders or beneficial owners
of the securities are subject to, and will be varied, if necessary, solely to give effect to, the exercise of any U.K. Bail-in Power by
the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment is not a waiver of any rights holders
or beneficial owners of the securities may have at law if and to the extent that any U.K. Bail-in Power is exercised by the relevant U.K.
resolution authority in breach of laws applicable in England.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, please see &ldquo;Selected
Risk Considerations&mdash;Risks Relating to the Issuer&mdash;You May Lose Some or All of Your Investment If Any U.K. Bail-in Power Is
Exercised by the Relevant U.K. Resolution Authority&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk
Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is
failing or likely to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers,
could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under
the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-size: 12pt">Investor
Considerations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities are not appropriate for all
investors. The securities <I>may</I> be an appropriate investment for you if all of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek a contingent fixed return at maturity
of at least 21.00% (to be provided in the pricing supplement) of the principal amount if the ending price of the lowest performing Underlying
Stock is greater than or equal to its threshold price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You anticipate that the ending price of the lowest
performing Underlying Stock will be greater than or equal to its threshold price, and you are willing and able to accept the risk that,
if it is not, you will lose more than 40%, and possibly all, of the principal amount of your securities at maturity. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand that if the ending price of the
lowest performing Underlying Stock is greater than or equal to its threshold price, the return you will receive at maturity will be limited
to the contingent fixed return, regardless of whether, and the extent to which, the ending price of the lowest performing Underlying Stock
exceeds its starting price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept the individual
market risk of each Underlying Stock and you understand that poor performance by either Underlying Stock over the term of the securities
may negatively affect your return and will not be offset or mitigated by any positive performance by the other Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept the risks
associated with an investment linked to the performance of the lowest performing Underlying Stock, as explained in more detail in the
&ldquo;Selected Risk Considerations&rdquo; section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand and accept that you will not be
entitled to receive dividends or distributions that may be paid to holders of the Underlying Stocks, nor will you have any voting rights
with respect to the Underlying Stocks.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment for which there
will be an active secondary market and you are willing and able to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to consent to the exercise
of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities may <I>not</I> be an appropriate
investment for you if <I>any</I> of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that provides for the
full repayment of principal at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You anticipate that the ending price of the lowest
performing Underlying Stock will be less than its threshold price, or you are unwilling or unable to accept the risk that, if it is, you
will lose more than 40%, and possibly all, of the principal amount of your securities at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that provides for full
exposure to the upside performance of the lowest performing Underlying Stock above the contingent fixed return.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept the individual
market risk of each Underlying Stock or the risk that poor performance by either Underlying Stock over the term of the securities may
negatively affect your return and will not be offset or mitigated by any positive performance by the other Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept the risks
associated with an investment linked to the performance of the lowest performing Underlying Stock, as explained in more detail in the
&ldquo;Selected Risk Considerations&rdquo; section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that entitles you to dividends
or distributions on, or voting rights related to, the Underlying Stocks.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment for which there will be
an active secondary market and/or you are unwilling or unable to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to consent to the
exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the securities are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>investment in the securities in light of your
particular circumstances. You should also review carefully the &ldquo;Selected Risk Considerations&rdquo; beginning on page PPS-10 of
this pricing supplement and the &ldquo;Risk Factors&rdquo; beginning on page PS-3 of the accompanying product supplement and the &ldquo;Risk
Factors&rdquo; beginning on page S-9 of the accompanying prospectus supplement for risks related to an investment in the securities. For
more information about the Underlying Stocks, please see the sections titled &ldquo;The Common Stock of Advanced Micro Devices, Inc.&rdquo;
and &ldquo;The Common Stock of NVIDIA Corporation&rdquo; below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-size: 12pt">Determining
the Maturity Payment Amount</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will receive
a cash payment per security (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Step 1: Determine which Underlying Stock is the
lowest performing Underlying Stock. The lowest performing Underlying Stock is the Underlying Stock that has the lowest stock return, calculated
for each Underlying Stock as the percentage change from its starting price to its ending price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Step 2: Calculate the maturity payment amount
based on the ending price of the lowest performing Underlying Stock, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-size: 12pt">Selected
Risk Considerations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities involves significant
risks. Investing in the securities is not equivalent to investing directly in either or both Underlying Stocks. Some of the risks that
apply to an investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks relating
to the securities generally in the &ldquo;Risk Factors&rdquo; sections of the product supplement and prospectus supplement. You should
not purchase the securities unless you understand and can bear the risks of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Securities
Generally</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>If The Ending Price Of The Lowest Performing
Underlying Stock Is Less Than Its Threshold Price, You Will Lose More Than 40%, And Possibly All, Of The Principal Amount Of Your Securities
At Maturity</B> &mdash; If the ending price of the lowest performing Underlying Stock is less than its threshold price, the maturity payment
amount will be less than the principal amount and you will have full downside exposure to the decrease in the price of that Underlying
Stock from its starting price. The threshold price for each Underlying Stock is 60% of its starting price. For example, if the lowest
performing Underlying Stock has declined by 40.1% from its starting price to its ending price, you will not receive any benefit from the
contingent downside feature and you will lose 40.1% of the principal amount. As a result, you will not receive any protection if the price
of the lowest performing Underlying Stock declines significantly and you may lose more than 40%, and possibly all, of the principal amount
at maturity, even if the price of the lowest performing Underlying Stock is greater than or equal to its starting price or its threshold
price at certain times during the term of the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; background-color: white"><B>The Potential Return
On The Securities Is Limited To The Contingent Fixed Return And May Be Lower Than The Return On A Direct Investment In Any Underlying
Stock </B>&mdash; The potential return on the securities is limited to the contingent fixed return, regardless of any appreciation of
any </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">Underlying Stock<FONT STYLE="background-color: white">, which may
be significant. Therefore, your return on the securities may be lower than the return on a direct investment in any </FONT>Underlying
Stock<FONT STYLE="background-color: white">.</FONT></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You Will Receive The Contingent Fixed Return
Only If The Ending Price Of The Lowest Performing Underlying Stock Is Greater Than Or Equal To Its Threshold Price</B> &mdash; You will
receive the contingent fixed return only if the ending price of the lowest performing Underlying Stock is greater than or equal to its
threshold price. If the ending price of the lowest performing Underlying Stock is less than its threshold price, then you will not receive
the contingent fixed return, and you will suffer a loss on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Periodic Interest Will Be Paid On The Securities
</B>&mdash; No periodic payments of interest will be made on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Are Subject To The Full Risks
Of Each Underlying Stock And Will Be Negatively Affected If Either Underlying Stock Performs Poorly, Even If The Other Underlying Stock
Performs Favorably</B> &mdash; You are subject to the full risks of each Underlying Stock. If either Underlying Stock performs poorly,
you will be negatively affected, even if the other Underlying Stock performs favorably. The securities are not linked to a basket composed
of the Underlying Stocks, where the better performance of one Underlying Stock could offset the poor performance of the other Underlying
Stock. Instead, you are subject to the full risks of whichever Underlying Stock is the lowest performing Underlying Stock. As a result,
the securities are riskier than an alternative investment linked to only one of the Underlying Stocks or linked to a basket composed of
both Underlying Stocks. You should not invest in the securities unless you understand and are willing to accept the full downside risks
of each Underlying Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Your Return On The Securities Will Depend
Solely On The Performance Of The Lowest Performing Underlying Stock, And You Will Not Benefit In Any Way From The Performance Of The Better
Performing Underlying Stock</B> &mdash; Your return on the securities will depend solely on the performance of the lowest performing Underlying
Stock. Although it is necessary for each Underlying Stock to close at or above its threshold price on the calculation day in order for
you to be repaid the principal amount of your securities at maturity, you will not benefit in any way from the performance of the better
performing Underlying Stock. The securities may underperform an alternative investment linked to a basket composed of the Underlying Stocks,
since in such case the performance of the better performing Underlying Stock would be blended with the performance of the lowest performing
Underlying Stock, resulting in a better return than the return of the lowest performing Underlying Stock alone.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You Will Be Subject To Risks Resulting From
The Relationship Between The Underlying Stocks</B> &mdash; The correlation of a pair of Underlying Stocks represents a statistical measurement
of the degree to which the returns of those Underlying Stocks are similar to each other over a given period in terms of timing and direction.
By investing in the securities, you assume the risk that the returns of the Underlying Stocks will not be correlated. The less correlated
the Underlying Stocks, the more likely it is that any one of the Underlying Stocks will be performing poorly at any time over the term
of the securities. All that is necessary for the securities to perform poorly is for one of the Underlying Stocks to perform poorly; the
performance of the better performing Underlying Stock is not relevant to your return on the securities. It is impossible to predict what
the relationship between the Underlying Stocks will be over the term of the securities. The Underlying Stocks may represent different
equity markets, and those equity markets may not perform similarly over the term of the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Any Payment On The Securities Will Be Determined
Based On The Stock Closing Prices Of The Underlying Stocks On The Dates Specified</B> &mdash; Any payment on the securities will be determined
based on the stock closing prices of the Underlying </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Stocks on the dates
specified. You will not benefit from any more favorable values of the Underlying Stocks determined at any other time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Owning The Securities Is Not The Same As Owning
Either Or Both Of The Underlying Stocks</B> &mdash; The return on your securities may not reflect the return you would realize if you
actually owned either or both of the Underlying Stocks. For instance, as a holder of the securities, you will not have voting rights or
rights to receive cash dividends or other distributions or any other rights that holders of either Underlying Stock would have.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Assurance That The Investment View Implicit
In The Securities Will Be Successful</B> &mdash; It is impossible to predict whether and the extent to which the price of either Underlying
Stock will rise or fall. There can be no assurance that the ending price of either Underlying Stock will not be less than its threshold
price. The price of each Underlying Stock will be influenced by complex and interrelated political, economic, financial and other factors
that affect that Underlying Stock. You should be willing to accept the downside risks associated with equities in general and each Underlying
Stock in particular, and the risk of losing a significant portion or all of the principal amount.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The U.S. Federal Income Tax Consequences Of
An Investment In The Securities Are Uncertain</B> &mdash; There is no direct legal authority regarding the proper U.S. federal income
tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;). Consequently,
significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of
the securities as prepaid forward contracts, as described below under &ldquo;Tax Considerations.&rdquo; If the IRS were successful in
asserting an alternative treatment for the securities, the tax consequences of the ownership and disposition of the securities could be
materially and adversely affected. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, in 2007
the Treasury Department and the IRS released a notice requesting comments on various issues regarding the U.S. federal income tax treatment
of &ldquo;prepaid forward contracts&rdquo; and similar instruments. Any Treasury regulations or other guidance promulgated after consideration
of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive
effect. You should review carefully the sections of the accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income
Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward Contracts&rdquo; and, if you are a non-U.S.
holder, &ldquo;&mdash;Tax Consequences to Non-U.S. Holders,&rdquo; and consult your tax advisor regarding the U.S. federal tax consequences
of an investment in the securities (including possible alternative treatments and the issues presented by the 2007 notice), as well as
tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Are Subject To The Credit Risk
Of Barclays Bank PLC</B> &mdash; The securities are unsecured and unsubordinated debt obligations of the issuer, Barclays Bank PLC, and
are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the securities, including any repayment
of principal, is subject to the ability of Barclays Bank PLC to satisfy its obligations as they come due and is not guaranteed by any
third party. As a result, the actual and perceived creditworthiness of Barclays Bank PLC may affect the market value of the securities
and, in the event Barclays Bank PLC were to default on its obligations, you might not receive any amount owed to you under the terms of
the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You May Lose Some Or All Of Your Investment
If Any U.K. Bail-In Power Is Exercised By The Relevant U.K. Resolution Authority &mdash; </B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority as set forth under &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement. Accordingly, any
U.K. Bail-in Power may be exercised in such a manner as to result in you and other holders and beneficial owners of the securities losing
all or a part of the value of your investment in the securities or receiving a different security from the securities, which may be worth
significantly less than the securities and which may have significantly fewer protections than those typically afforded to debt securities.
Moreover, the relevant U.K. resolution authority may exercise the U.K. Bail-in Power without providing any advance notice to, or requiring
the consent of, the holders and beneficial owners of the securities. The exercise of any U.K. Bail-in Power by the relevant U.K. resolution
authority with respect to the securities will not be a default or an Event of Default (as each term is defined in the senior debt securities
indenture) and the trustee will not be liable for any action that the trustee takes, or abstains from taking, in either case, in accordance
with the exercise of the U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the securities. See &ldquo;Consent
to U.K. Bail-in Power&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks Relating
to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is failing or likely to fail,
including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially adversely
affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under the terms
of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Underlying
Stocks</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>There Are Risks Associated With Single Equities
</B>&mdash; The price of each Underlying Stock can rise or fall sharply due to factors specific to that Underlying Stock and its issuer,
such as stock price volatility, earnings, financial conditions, corporate, industry and </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">regulatory developments,
management changes and decisions and other events, as well as general market factors, such as general stock market volatility and levels,
interest rates and economic and political conditions. We urge you to review financial and other information filed periodically with the
SEC by the issuer of each Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We Cannot Control Actions By An Underlying
Stock Issuer</B> &mdash; Actions by an Underlying Stock Issuer may have an adverse effect on the price of such Underlying Stock, the ending
price of such Underlying Stock, and the value of the securities. We are not affiliated with either Underlying Stock Issuer. No Underlying
Stock Issuer will be involved in the offering of the securities nor will either Underlying Stock Issuer have any obligations with respect
to the securities, including any obligation to take our interests or your interests into consideration for any reason. No Underlying Stock
Issuer will receive any of the proceeds of the offering of the securities nor will be responsible for, or will have participated in, the
determination of the timing of, prices for, or quantities of, the securities to be issued. No Underlying Stock Issuer will be involved
with the administration, marketing or trading of the securities nor will have any obligations with respect to any amounts payable on the
securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We And Our Affiliates Have No Affiliation
With Either Underlying Stock Issuer And Have Not Independently Verified Their Public Disclosure Of Information</B> &mdash; We, our affiliates
and WFS and its affiliates are not affiliated in any way with either Underlying Stock Issuer. This pricing supplement relates only to
the securities and does not relate to either Underlying Stock. The material provided in this pricing supplement concerning an Underlying
Stock Issuer is derived from publicly available documents without independent verification. Neither we nor either agent has participated
in the preparation of any of those documents or made any &ldquo;due diligence&rdquo; investigation or any inquiry of the Underlying Stock
Issuers. Furthermore, neither we nor either agent knows whether either Underlying Stock Issuer has disclosed all events occurring before
the date of this pricing supplement, including events that could affect the accuracy or completeness of the publicly available documents
referred to above. Subsequent disclosure of any event of this kind or the disclosure of or failure to disclose material future events
concerning an Underlying Stock Issuer could affect the value of the securities and any payments on the securities. You, as an investor
in the securities, should make your own investigation into each Underlying Stock Issuer.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You Have Limited Anti-dilution Protection</B>
&mdash; The calculation agent will, in its sole discretion, adjust the adjustment factor of an Underlying Stock for certain events affecting
such Underlying Stock, such as stock splits and stock dividends, and certain other corporate actions involving the applicable Underlying
Stock Issuer, such as mergers. However, the calculation agent is not required to make an adjustment for every corporate event that can
affect an Underlying Stock. For example, the calculation agent is not required to make any adjustments to the adjustment factor of an
Underlying Stock if the applicable Underlying Stock Issuer or anyone else makes a partial tender or partial exchange offer for such Underlying
Stock. Consequently, this could affect the value of the securities and any payments on the securities. See &ldquo;General Terms of the
Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment Events&rdquo; in the accompanying product
supplement for a description of the general circumstances in which the calculation agent will make adjustments to the adjustment factor
of an Underlying Stock. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities May Become Linked To The Common
Stock Of A Company Other Than An Original Underlying Stock Issuer </B>&mdash; Following certain corporate events relating to an Underlying
Stock, such as a stock-for-stock merger where the applicable Underlying Stock Issuer is not the surviving entity, the shares of a successor
corporation to such Underlying Stock Issuer will be substituted for such Underlying Stock for all purposes of the securities. Following
certain other corporate events relating to an Underlying Stock in which holders of such Underlying Stock would receive all of their consideration
in cash and the surviving entity has no marketable securities outstanding or there is no surviving entity (including, but not limited
to, a leveraged buyout or other going private transaction involving such Underlying Stock Issuer, or a liquidation of such Underlying
Stock Issuer), the common stock of another company in the same industry group as such Underlying Stock Issuer will be substituted for
such Underlying Stock for all purposes of the securities. In any such event, the equity-linked nature of the securities would be significantly
altered. See &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Adjustment
Events&rdquo; in the accompanying product supplement for a description of the specific events that can lead to these adjustments and the
procedures for selecting a replacement stock. The occurrence of such events and the consequent adjustments may materially and adversely
affect the value of the securities and any payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Historical Performance Of The Underlying
Stocks Is Not An Indication Of Their Future Performance &mdash;</B> The historical performance of the Underlying Stocks should not be
taken as an indication of the future performance of the Underlying Stocks. It is impossible to predict whether the stock closing prices
of the Underlying Stocks will fall or rise during the term of the securities, in particular in the environment in the last several years,
which has been characterized by volatility across a wide range of asset classes. Past fluctuations and trends in the prices of the Underlying
Stocks are not necessarily indicative of fluctuations or trends that may occur in the future.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to Conflicts
of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Potentially Inconsistent Research, Opinions
Or Recommendations By Barclays Capital Inc., WFS Or Their Respective Affiliates</B> &mdash; Barclays Capital Inc., WFS or their respective
affiliates may publish research from time to time on financial markets and other matters that may influence the value of the securities
or express opinions or provide recommendations that are inconsistent with purchasing or holding the securities. Any research, opinions
or recommendations expressed by Barclays Capital Inc., WFA or their respective affiliates may not be consistent with each other and may
be modified from time to time without notice. You should make your own independent investigation of each Underlying Stock and the merits
of investing in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We, Our Affiliates And Any Other Agent And/Or
Participating Dealer May Engage In Various Activities Or Make Determinations That Could Materially Affect Your Securities In Various Ways
And Create Conflicts Of Interest</B> &mdash; We, our affiliates, WFS and any dealer participating in the distribution of the securities
(a &ldquo;<U>participating dealer</U>&rdquo;) may play a variety of roles in connection with the issuance of the securities, as described
below. In performing these roles, our economic interests and the economic interests of our affiliates, WFS and any participating dealer
are potentially adverse to your interests as an investor in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In connection with
our normal business activities and in connection with hedging our obligations under the securities, we and our affiliates make markets
in and trade various financial instruments or products for our accounts and for the account of our clients and otherwise provide investment
banking and other financial services with respect to these financial instruments and products. These financial instruments and products
may include securities, derivative instruments or assets that may relate to the Underlying Stocks. In any such market making, trading
and hedging activity, investment banking and other financial services, we or our affiliates may take positions or take actions that are
inconsistent with, or adverse to, the investment objectives of the holders of the securities. We and our affiliates have no obligation
to take the needs of any buyer, seller or holder of the securities into account in conducting these activities. Such market making, trading
and hedging activity, investment banking and other financial services may negatively impact the value of the securities. Participating
dealers may also engage in such activities that may negatively impact the value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, the
role played by Barclays Capital Inc., as the agent for the securities, could present significant conflicts of interest with the role of
Barclays Bank PLC, as issuer of the securities. For example, Barclays Capital Inc. or its representatives may derive compensation or financial
benefit from the distribution of the securities and such compensation or financial benefit may serve as an incentive to sell the securities
instead of other investments. Furthermore, we and our affiliates establish the offering price of the securities for initial sale to the
public, and the offering price is not based upon any independent verification or valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Furthermore, if any
dealer participating in the distribution of the securities or any of its affiliates conducts hedging activities for us in connection with
the securities, that participating dealer or its affiliates will expect to realize a projected profit from such hedging activities, and
this projected profit will be in addition to any selling concession and/or any fee that the participating dealer realizes for the sale
of the securities to you. This additional projected profit may create a further incentive for the participating dealer to sell the securities
to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In addition to the activities described
above, Barclays Bank PLC will also act as the calculation agent for the securities. As calculation agent, we will determine any prices
of the Underlying Stocks and make any other determinations necessary to calculate any payments on the securities. In making these determinations,
we may be required to make discretionary judgments, including those described in the accompanying product supplement and under &ldquo;&mdash;Risks
Relating to the Underlying Stocks&rdquo; above. In making these discretionary judgments, our economic interests are potentially adverse
to your interests as an investor in the securities, and any of these determinations may adversely affect any payments on the securities.
Absent manifest error, all determinations of the calculation agent will be final and binding, without any liability on the part of the
calculation agent. You will not be entitled to any compensation from Barclays Bank PLC for any loss suffered as a result of any determinations
made by the calculation agent with respect to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Estimated
Value of the Securities and the Secondary Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Will Not Be Listed On Any Securities
Exchange And We Do Not Expect A Trading Market For The Securities To Develop</B> &mdash; The securities will not be listed on any securities
exchange. Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to make a secondary market for the securities but are
not required to do so, and may discontinue any such secondary market making at any time, without notice. Even if there is a secondary
market, it may not provide enough liquidity to allow you to trade or sell the securities easily. Because other dealers are not likely
to make a secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the
price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC are willing to buy the securities. The securities
are not designed to be short-term trading instruments. Accordingly, you should be willing and able to hold your securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Value Of The Securities Prior To Maturity
Will Be Affected By Numerous Factors, Some Of Which Are Related In Complex Ways</B> &mdash; Structured notes, including the securities,
can be thought of as securities that combine a debt instrument with one or more options or other derivative instruments. As a result,
the factors that influence the values of debt instruments and options or other derivative instruments will also influence the terms and
features of the securities at issuance and their value in the secondary market. Accordingly, in addition to the prices of the Underlying
Stocks on any day, the value of the securities will be affected by a number of economic and market factors that may either offset or magnify
each other, including:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the expected volatility of the Underlying Stocks;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">correlation (or lack of correlation) of the Underlying
Stocks;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the time to maturity of the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the market prices of, and dividend rates on,
the Underlying Stocks;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">interest and yield rates in the market generally;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">supply and demand for the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a variety of economic, financial, political,
regulatory and judicial events; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our creditworthiness, including actual or anticipated
downgrades in our credit ratings.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Expected To Be Lower Than The Original Offering Price Of Your Securities</B> &mdash; The estimated value of your securities on the pricing
date is expected to be lower, and may be significantly lower, than the original offering price of your securities. The difference between
the original offering price of your securities and the estimated value of the securities is expected as a result of certain factors, such
as any sales commissions, selling concessions, discounts, commissions or fees expected to be allowed or paid to Barclays Capital Inc.,
another affiliate of ours, WFS or its affiliates or other non-affiliated intermediaries, the estimated profit that we or any of our affiliates
expect to earn in connection with structuring the securities, the estimated cost that we may incur in hedging our obligations under the
securities, and estimated development and other costs that we may incur in connection with the securities.&#9;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Might
Be Lower If Such Estimated Value Were Based On The Levels At Which Our Debt Securities Trade In The Secondary Market</B> &mdash; The estimated
value of your securities on the pricing date is based on a number of variables, including our internal funding rates. Our internal funding
rates may vary from the levels at which our benchmark debt securities trade in the secondary market. As a result of this difference, the
estimated values referenced above might be lower if such estimated values were based on the levels at which our benchmark debt securities
trade in the secondary market.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of The Securities Is Based
On Our Internal Pricing Models, Which May Prove To Be Inaccurate And May Be Different From The Pricing Models Of Other Financial Institutions</B>
&mdash; The estimated value of your securities on the pricing date is based on our internal pricing models, which take into account a
number of variables and are based on a number of subjective assumptions, which may or may not materialize. These variables and assumptions
are not evaluated or verified on an independent basis. Further, our pricing models may be different from other financial institutions&rsquo;
pricing models and the methodologies used by us to estimate the value of the securities may not be consistent with those of other financial
institutions that may be purchasers or sellers of securities in the secondary market. As a result, the secondary market price of your
securities may be materially different from the estimated value of the securities determined by reference to our internal pricing models.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Not A Prediction Of The Prices At Which You May Sell Your Securities In The Secondary Market, If Any, And Such Secondary Market Prices,
If Any, Will Likely Be Lower Than The Original Offering Price Of Your Securities And May Be Lower Than The Estimated Value Of Your Securities</B>
&mdash; The estimated value of the securities will not be a prediction of the prices at which Barclays Capital Inc., other affiliates
of ours or third parties may be willing to purchase the securities from you in secondary market transactions (if they are willing to purchase,
which they are not obligated to do). The price at which you may be able to sell your securities in the secondary market at any time will
be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades,
and may be substantially less than our estimated value of the securities. Further, as secondary market prices of your securities take
into account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs related
to the securities such as fees, commissions, discounts, and the costs of hedging our obligations under the securities, secondary market
prices of your securities will likely be lower than the original offering price of your securities. As a result, the price at which Barclays
Capital Inc., other affiliates of ours or third parties may be willing to purchase the securities from you in secondary market transactions,
if any, will likely be lower than the price you paid for your securities, and any sale prior to the stated maturity date could result
in a substantial loss to you.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Temporary Price At Which We May Initially
Buy The Securities In The Secondary Market And The Value We May Initially Use For Customer Account Statements, If We Provide Any Customer
Account Statements At All, May Not Be Indicative Of Future Prices Of Your Securities</B> &mdash; Assuming that all relevant factors remain
constant after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market
(if Barclays Capital Inc. makes a market in the securities, which it is not obligated to do) and the value that we may initially use for
customer account statements, if we provide any customer account statements at all, may exceed our estimated value of the securities on
the pricing date, as well as the secondary market value of the securities, for a temporary period after the initial issue date of the
securities. The price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market and the value that
we may initially use for customer account statements may not be indicative of future prices of your securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-size: 12pt">Hypothetical
Examples and Returns</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The payout profile, return table and examples
below illustrate the maturity payment amount for a $1,000 principal amount security on a hypothetical offering of securities under various
scenarios, with the assumptions set forth in the table below. Terms used for purposes of these hypothetical examples do not represent
the actual starting price, threshold price or ending price of either Underlying Stock applicable to the securities. The actual maturity
payment amount and resulting pre-tax total rate of return will depend on the actual terms of the securities. You should not take these
examples as an indication or assurance of the expected performance of the securities. These examples are for purposes of illustration
only. The values used in the examples may have been rounded for ease of analysis. The examples below do not take into account any tax
consequences from investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 36%; border: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Contingent Fixed Return: </B></FONT></TD>
    <TD STYLE="width: 64%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">21.00% of the principal amount or $210.00 per security (the lowest possible contingent fixed return that may be determined on the pricing date)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Starting Price: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">For each Underlying Stock, $100.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Threshold Price: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">For each Underlying Stock, $60.00 (60% of its hypothetical starting price)</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The hypothetical starting price of $100.00 for
each Underlying Stock has been chosen for illustrative purposes only and does not represent the actual starting price of either Underlying
Stock. For each Underlying Stock, the actual starting price will be the stock closing price of that Underlying Stock on the pricing date,
the actual threshold price will be 60% of its actual starting price and the actual ending price will be the stock closing price of that
Underlying Stock on the calculation day. For historical closing prices of the Underlying Stocks, see the historical information set forth
under the sections titled &ldquo;The Common Stock of Advanced Micro Devices, Inc.&rdquo; and &ldquo;The Common Stock of NVIDIA Corporation&rdquo;
below. We cannot predict the stock closing price of the Underlying Stocks on any day during the term of the securities, including on the
calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Payout Profile</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 349px; width: 557px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Returns</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 25%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
ending price of the lowest performing Underlying Stock</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
stock return of the lowest performing Underlying Stock</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical maturity payment amount per security</B></FONT></TD>
    <TD STYLE="width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical pre-tax total rate of return</B></FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$175.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$140.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$130.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$121.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$120.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$110.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$105.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$100.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$95.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-5.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$90.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$75.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-25.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR STYLE="background-color: #D9D9D9">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$60.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-40.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,210.00</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$59.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-41.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$590.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-41.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$50.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$500.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-50.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-75.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$250.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-75.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-100.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Hypothetical Examples</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1. Maturity payment amount is greater
than the principal amount and reflects a return that is equal to the contingent fixed return, which is greater than the percentage increase
in the stock closing price of the lowest performing Underlying Stock from its hypothetical starting price to its hypothetical ending price:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; width: 64%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AMD Stock</B></FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NVDA Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting price:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending price:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$110.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$190.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold price: </B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical stock return: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">90.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 1</U>: Determine which Underlying Stock
is the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this example, the AMD Stock has the lowest
stock return and is, therefore, the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 2</U>: Determine the maturity payment
amount based on the ending price of the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price of the lowest
performing Underlying Stock is greater than or equal to its hypothetical threshold price, the maturity payment amount per security would
be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">$1,000 +
the contingent fixed return of $210.00;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">= $1,210.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,210.00 per security, which is the maximum maturity payment amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. Maturity payment amount is greater
than the principal amount and reflects a return equal to the contingent fixed return, which is less than the percentage increase in the
stock closing price of the lowest performing Underlying Stock from its hypothetical starting price to its hypothetical ending price:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; width: 64%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AMD Stock</B></FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NVDA Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting price:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending price:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$150.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$130.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold price: </B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical stock return: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">50.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">30.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 1</U>: Determine which Underlying Stock
is the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this example, the NVDA Stock has the lowest
stock return and is, therefore, the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 2</U>: Determine the maturity payment
amount based on the ending price of the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price of the lowest
performing Underlying Stock is greater than or equal to its hypothetical threshold price, the maturity payment amount per security would
be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + the contingent fixed return of $210.00;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="background-color: white">= $1,210.00</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,210.00 per security, which is the maximum maturity payment amount. Even though the lowest performing Underlying Stock increased by
30% from its hypothetical starting price to its hypothetical ending price in this example, your return is limited to the contingent fixed
return of 21.00%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3. Maturity payment amount is greater
than the principal amount and reflects a return equal to the contingent fixed return, even though the ending price of the lowest performing
Underlying Stock is less than its starting price but is greater than its threshold price:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; width: 64%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AMD Stock</B></FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NVDA Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting price:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending price:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$95.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$90.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold price: </B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical stock return: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">-5.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">-10.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 1</U>: Determine which Underlying Stock
is the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this example, the NVDA Stock has the lowest
stock return and is, therefore, the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 2</U>: Determine the maturity payment
amount based on the ending price of the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price of the lowest
performing Underlying Stock is greater than or equal to its hypothetical threshold price, the maturity payment amount per security would
be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + the contingent fixed return of $210.00;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,210.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,210.00 per security, which is the maximum maturity payment amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 4. Maturity payment amount is less
than the principal amount:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse">
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom; width: 64%; border: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>AMD Stock</B></FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NVDA Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting price:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending price:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$50.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$120.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold price: </B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$60.00</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font-size: 12pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical stock return: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">-50.00%</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">20.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 1</U>: Determine which Underlying Stock
is the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this example, the AMD Stock has the lowest
stock return and is, therefore, the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Step 2</U>: Determine the maturity payment
amount based on the ending price of the lowest performing Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending price of the lowest
performing Underlying Stock is less than its hypothetical starting price by more than 40%, you would lose a portion of the principal amount
of your securities and receive the maturity payment amount equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + ($1,000 &times; stock return of the lowest
performing Underlying Stock)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 + ($1,000 &times; -50.00%)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $500.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$500.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This example illustrates that you will be fully
exposed to a decrease in the lowest performing Underlying Stock if the ending price of the lowest performing Underlying Stock is less
than its threshold price, even if the ending price of the other Underlying Stock has appreciated or has not declined below its threshold
price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="padding: 4pt; color: white; font: bold 12pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; background-color: #4F81BD"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Information
about the Underlying Stocks</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We urge you to read the following section in the
accompanying prospectus supplement: &ldquo;Reference Assets &mdash; Equity Securities &mdash; Reference Asset Issuer and Reference Asset
Information.&rdquo; Companies with securities registered under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;),
are required to file financial and other information specified by the SEC periodically. Such information can be reviewed electronically
through a website maintained by the SEC at http://www.sec.gov. Information filed with the SEC by the issuer of each Underlying Stock can
be located by reference to its SEC file number provided below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Included below is a brief description of the issuer
of each Underlying Stock. This information has been obtained from publicly available sources. Information from outside sources is not
incorporated by reference in, and should not be considered part of, this pricing supplement or any accompanying prospectus or prospectus
supplement. We have not independently verified the accuracy or completeness of the information contained in outside sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Common Stock of Advanced Micro Devices, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to publicly available information, Advanced
Micro Devices, Inc. is a semiconductor company whose products include Artificial Intelligence (AI) accelerators, microprocessors (CPUs)
for servers and graphics processing units (GPUs), as standalone devices or as incorporated into accelerated processing units (APUs), chipsets,
data center and professional GPUs, embedded processors, semi-custom System-on-Chip (SOC) products, microprocessor and SoC development
services and technology, data processing units (DPUs), Field Programmable Gate Arrays (FPGAs), System on Modules (SOMs), Smart Network
Interface Cards (SmartNICs) and Adaptive SoC products and that, from time to time, may also sell or license portions of its intellectual
property portfolio. Information filed by Advanced Micro Devices, Inc. with the SEC under the Exchange Act can be located by reference
to its SEC file number: 001-07882. The AMD Stock is listed on The Nasdaq Stock Market under the ticker symbol &ldquo;AMD.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing prices of the AMD Stock
displayed in the graph below from Bloomberg Professional<SUP>&reg;</SUP> service (&ldquo;Bloomberg&rdquo;) without independent verification.
The historical performance of the AMD Stock should not be taken as an indication of the future performance of the AMD Stock. Future performance
of the AMD Stock may differ significantly from historical performance, and no assurance can be given as to the closing prices of the AMD
Stock during the term of the securities, including on the calculation day. We cannot give you assurance that the performance of the AMD
Stock will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing prices
of the AMD Stock for the period from January 1, 2020 to November 24, 2025. The closing price on November 24, 2025 was $215.05. <I>The
closing prices below may reflect adjustments in response to certain corporate actions, such as stock splits, public offerings, mergers
and acquisitions, spin-offs, extraordinary dividends, delistings and bankruptcy.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 321px; width: 614px"></FONT>&nbsp;</P>
    <P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">* The dotted line indicates a hypothetical
threshold price of 60% of the closing price of the AMD Stock on November 24, 2025. The actual threshold price will be equal to 60% of
the starting price of the AMD Stock.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE
RESULTS.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Common Stock of NVIDIA Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to publicly available information, NVIDIA
Corporation is a full-stack computing infrastructure company with data-center-scale offerings whose full-stack includes the CUDA programming
model that runs on all of its graphics processing units (GPUs), as well as domain-specific software libraries, software development kits
and Application Programming Interfaces. Information filed by NVIDIA Corporation with the SEC under the Exchange Act can be located by
reference to its SEC file number: 000-23985. The NVDA Stock is listed on The Nasdaq Stock Market under the ticker symbol &ldquo;NVDA.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing prices of the NVDA Stock
displayed in the graph below from Bloomberg without independent verification. The historical performance of the NVDA Stock should not
be taken as an indication of the future performance of the NVDA Stock. Future performance of the NVDA Stock may differ significantly from
historical performance, and no assurance can be given as to the closing prices of the NVDA Stock during the term of the securities, including
on the calculation day. We cannot give you assurance that the performance of the NVDA Stock will not result in a loss on your initial
investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing prices
of the NVDA Stock for the period from January 1, 2020 to November 24, 2025. The closing price on November 24, 2025 was $182.55. <I>The
closing prices below may reflect adjustments in response to certain corporate actions, such as stock splits, public offerings, mergers
and acquisitions, spin-offs, extraordinary dividends, delistings and bankruptcy.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><IMG SRC="image_005.jpg" ALT="" STYLE="height: 322px; width: 614px"></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">* The dotted line indicates a hypothetical threshold price of 60% of the closing price of the NVDA Stock on November 24, 2025. The actual threshold price will be equal to 60% of the starting price of the NVDA Stock.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Contingent Fixed Return and Contingent Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Lowest Performing of the Common Stock of Advanced Micro Devices, Inc. and the Common Stock of NVIDIA Corporation due December 30, 2026</B></P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #4F81BD"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Tax
Considerations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should review carefully the sections in the
accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes
Treated as Prepaid Forward Contracts&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax Consequences to Non-U.S. Holders.&rdquo;
The following discussion, when read in combination with those sections, constitutes the full opinion of our special tax counsel, Davis
Polk &amp; Wardwell LLP, regarding the material U.S. federal income tax consequences of owning and disposing of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on current market conditions, in the opinion
of our special tax counsel, it is reasonable to treat the securities for U.S. federal income tax purposes as prepaid forward contracts
with respect to the Underlying Stocks. Assuming this treatment is respected, if you are a U.S. holder, upon a sale or exchange of the
securities (including redemption at maturity), you should recognize capital gain or loss equal to the difference between the amount realized
on the sale or exchange and your tax basis in the securities, which should equal the amount you paid to acquire the securities. This gain
or loss on your securities should be treated as long-term capital gain or loss if you hold your securities for more than a year, whether
or not you are an initial purchaser of the securities at the original issue price. The deductibility of capital losses is subject to limitations.
However, the IRS or a court may not respect this treatment, in which case the timing and character of any income or loss on the securities
could be materially and adversely affected. In addition, in 2007 the U.S. Treasury Department and the IRS released a notice requesting
comments on the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and similar instruments. The notice focuses
in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for
comments on a number of related topics, including the character of income or loss with respect to these instruments; the relevance of
factors such as the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including
any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should
be subject to the &ldquo;constructive ownership&rdquo; regime, which very generally can operate to recharacterize certain long-term capital
gain as ordinary income and impose a notional interest charge. While the notice requests comments on appropriate transition rules and
effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely
affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should consult your tax advisor
regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments and the
issues presented by this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Treasury regulations under Section 871(m) generally
impose a withholding tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity linked instruments.&rdquo; A recent
IRS notice excludes from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a &ldquo;delta of one&rdquo;
with respect to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an &ldquo;Underlying
Security&rdquo;). Based on our representation that the securities do not have a &ldquo;delta of one&rdquo; within the meaning of the regulations,
our special tax counsel believes that these regulations should not apply to the securities with regard to non-U.S. holders, and we have
determined to treat the securities as not being subject to Section 871(m). Our determination is not binding on the IRS, and the IRS may
disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including
whether you enter into other transactions with respect to an Underlying Security. If necessary, further information regarding the potential
application of Section 871(m) will be provided in the pricing supplement for the securities. You should consult your tax advisor regarding
the potential application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-U.S. holders should also discuss with their
tax advisors the estate tax consequences of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PPS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  J +,# 2(  A$! Q$!_\0
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MO;H[H[-!#"#Z^OY5:\5Z%<RW*:EI^XS1@!E7[W'1A_A5CP,!_8.1U\ULT?\
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CD([LH-6**+@XI[HCCACB4+&H51T"C J2BB@:5@HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $E KD# 2(  A$! Q$!_\0
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M;UQAZ_Z,/YS T?\ "RX?^A9US\[7_P"/URI!!P1@U8@L;FY($<?WD9UW$+N
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M#6/^_%G_ /(]'V/6_P#H<-8_[\6?_P CUHT4<\NX&=]CUO\ Z'#6/^_%G_\
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M,5:-EY%\SV]DGVCSX"R&$$)&5&Y@"./FR"1TQVKEGLKJ*)I9+:9(U;:S-&0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-X=O[.2.[CO'TR.Q'VF6W\I_+R0L8B7.PY8;GPV&Z'G'HU%',P.)U73-2O\
M[!J-II-SIKP732S6]LUJ;B3=$8]_S;HB1P.6SMST( H_X1V8Q:'I3Z==/I\5
MA<6LTCS1,8E=5"AL%22 O\*D XP3UKMJ*.8#AK[0]=GLM'OIC.VHV\Q>[6R:
M$NW[HQAD\X%/<@]-[8.>K[^UDT7P]X7M8[*XN&M;Z)$MS+&TI 23 W':FX#'
MH., GK7;55O-,L-1,1OK&VNC"V^+SXE?8WJN1P?I1S >?3^$=6=%EEAO1;W<
M=Y'-96,EMOMUGEW["905QC[Q0Y! QD<UTD.ES/XNCGN]),L$>GQ0I=R-%(JR
MHY?C)#YSMYVCD9XXKIZ*.9@>?ZWX=U?5+G5X+*"ZM8KI)2WGR0O;RL4"J8R,
MR(S8 8$;<;NIQE8-"U*"\@U<Z?J-VRWAFGM+N6U\V0F Q;U$>V(8&T<MDC=T
MX![^BCF8' Z]H^JDW(T_0LQ76DQV:16TT2I;LDC-M.YEXVL -H(R,<#FK%SI
MEW=2^*+AO#\OVBZA LY': LQ\GR\ [_EZMUQP3ZXKMJ*.8#@VT_4$TW7/M-A
M+:%XH+VVN9)(V6.:&*,!6"N3D/'G@8(SS7116\R7VEO+H\$LS+-)/>;TS:.P
M!*KD;F#?=R.RC-:=Q9VMV83<VT,QAD$L1EC#>6XZ,N>A'J*GHN 4445(!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOD?:K,^,X&6)(Z<XJ#484M]*GAC&$CU*5%'L% %._1"<7NS$KMOAM_R)4/\
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M$<(P#KR>&R/F/J<ET!A_\)A?7.FWFN6D=NFF631++;2Q,TTNY(Y&(<, N!*
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M&,'86   8C(P.>!5>+PEH\-S!<)'=>;!</=1DWTY E;AFP7P<C(P>.3ZG)=
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3U'_ ,";3_X_7KM%7[21'LHGD7]E>)O^A3U'_P ";3_X_1_97B;_ *%/4?\
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MO0Y].$]]J4L<VJW6/-:/.R)!G;$F>=HR3GJQ)/' &]77"/*K$A1115 %%%%
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MY_W[L_\ Y'H_X0VY_P"ANUS_ +]V?_R/7544<L>P'*_\(;<_]#=KG_?NS_\
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M7544<L>P'*_\(;<_]#=KG_?NS_\ D>C_ (0VY_Z&[7/^_=G_ /(]=511RQ[
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M%%%, HHHH **** "LZT\/Z+80W,-GI%A;Q77_'PD-LB++U^\ /FZGKZUHT4
M4VTG37U1-4;3[5M01/+6[,*F55Y^4/C(')XSWJY139)$AC:25U1%&2S' 'XT
M <ZO_(^/_P!>_P#2NDKF1(@\<&7>OEFUW;L\8QUSZ5TD<B31K)$ZNC#(93D&
MJET(CU'4445)84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4%[:1WUG
M+;2_<D7!/IZ&IZ* /,?L]]_:?]G9/G_\>_7^'.?RQ^E>CV5K'8V<5M%]R-<
M^OJ:C_LVV_M,:AL_TC9LSV^OUQQGTJW5RE<B$.4****@L**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHYF%BA]FUS_H;]7_ ._%G_\ (]'V;7/^AOU?_OQ9_P#R/5^BCF86*'V;7/\
MH;]7_P"_%G_\CT?9M<_Z&_5_^_%G_P#(]7Z*.9A8H?9M<_Z&_5_^_%G_ /(]
M'V;7/^AOU?\ [\6?_P CU?HHYF%BA]FUS_H;]7_[\6?_ ,CT?9M<_P"AOU?_
M +\6?_R/5^BCF86*'V;7/^AOU?\ [\6?_P CT?9M<_Z&_5_^_%G_ /(]7Z*.
M9A8H?9M<_P"AOU?_ +\6?_R/1]FUS_H;]7_[\6?_ ,CU?HHYF%BA]FUS_H;]
M7_[\6?\ \CT?9M<_Z&_5_P#OQ9__ "/5^BCF86*'V;7/^AOU?_OQ9_\ R/1]
MFUS_ *&_5_\ OQ9__(]7Z*.9A8H?9M<_Z&_5_P#OQ9__ "/1]FUS_H;]7_[\
M6?\ \CU?HHYF%BA]FUS_ *&_5_\ OQ9__(]'V;7/^AOU?_OQ9_\ R/5^BCF8
M6*'V;7/^AOU?_OQ9_P#R/1]FUS_H;]7_ ._%G_\ (]7Z*.9A8H?9M<_Z&_5_
M^_%G_P#(]'V;7/\ H;]7_P"_%G_\CU?HHYF%BA]FUS_H;]7_ ._%G_\ (]'V
M;7/^AOU?_OQ9_P#R/5^BCF86*'V;7/\ H;]7_P"_%G_\CT?9M<_Z&_5_^_%G
M_P#(]7Z*.9A8H?9M<_Z&_5_^_%G_ /(]'V;7/^AOU?\ [\6?_P CU?HHYF%B
MA]FUS_H;]7_[\6?_ ,CT?9M<_P"AOU?_ +\6?_R/5^BCF86*'V;7/^AOU?\
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MH ZB]M_#PT.T&H:=9_V8I0Q136JM%"6X!Q@J@YQG@#/6ME$6-%1%"HHPJJ,
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MO]TD9'X5&VAZ0[W3MI5BS78Q<DVZ$S#K\_'S?C5^B@"A_8FD@VA_LNRS9_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYZ#'-R^\1:Q;ZQ?6L=JAV1.UG;O:R;KG$88,DN[8QSD&/ ;CKWK9F\-Z1-)
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M ([1_P ('H?]_5__  =WG_QVBBBP!_P@>A_W]7_\'=Y_\=H_X0/0_P"_J_\
MX.[S_P".T446 /\ A ]#_OZO_P"#N\_^.T?\('H?]_5__!W>?_':**+ '_"!
MZ'_?U?\ \'=Y_P#':/\ A ]#_OZO_P"#N\_^.T446 /^$#T/^_J__@[O/_CM
M'_"!Z'_?U?\ \'=Y_P#':**+ '_"!Z'_ ']7_P#!W>?_ !VC_A ]#_OZO_X.
M[S_X[1118 _X0/0_[^K_ /@[O/\ X[1_P@>A_P!_5_\ P=WG_P =HHHL ?\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %= BT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQT__ )!MK_UQ3^0H LT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJSAW6\KKEHB74':>V:[C3_\ D&VO_7%/Y"N3^+G_ "2KQ!_UP7_T-:ZS3_\
MD&VO_7%/Y"@"S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !15:YO8K8,O,LP7>((^9&&<<#\:KBWN[V19+F0PVS1%7M  2200=S?X8
MH EDU >?%#;Q/<%R09(\%(P.#N;I^'6HHM-:9$;5'2[E1S(@";40^@'?'J<U
M=@@AM85A@C2.-1A508 J2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;7DL<;V>@7KJS ES&Q&WOC Y-,M?$;6K2/\ V#K$TCOO+S(S$'VXP!]*[4
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M-6MVNG_#[4-/FCN6FOXBL31PLR*592=S#A?QKO=/_P"0;:_]<4_D* +-%%%
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MIN-%M+JP^PR^:;81+$L8<C;M(*L#U# @<^U4G\(:9)#L+70D8R&2=9V$DH?
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M\9V=W$98K:?9OMD^; .9FV_^.D'/Z59D\)Z8SB5/M$,Z^7LFBF*NFQ"@P?\
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MOS'K@\<=* .JHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI88\J;&/]?)TV_WC_=_KSZ\U;JK8,&BEPP.)I!PRG^(_W0/R//K5J@ HHHH
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MT5P7]N?$O_H3=*_\&@_^)H_MSXE_]";I7_@T'_Q- '>T5P7]N?$O_H3=*_\
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M7_T)NE?^#0?_ !-']N?$O_H3=*_\&@_^)H [VBN"_MSXE_\ 0FZ5_P"#0?\
MQ-4=8\9?$'0M(N=3O?!VG"VMUWR&/4MS8SC@!>>M 'I=%>?Q>(/B3-"DJ>#M
M+VNH89U0=#_P&G_VY\2_^A-TK_P:#_XF@#O:*X+^W/B7_P!";I7_ (-!_P#$
MT?VY\2_^A-TK_P &@_\ B: .]HK@O[<^)?\ T)NE?^#0?_$UG:MXV\?Z*+(W
MG@[3Q]LNX[.+9J.[]X^=N<+P..IX% 'IU%<%_;GQ+_Z$W2O_  :#_P")H_MS
MXE_]";I7_@T'_P 30!WM%<%_;GQ+_P"A-TK_ ,&@_P#B:/[<^)?_ $)NE?\
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M=M?M9/#=WK5GNGA@BFDVL"A8Q[MRG(R.5(Z5B7OA.:T@T^XL7DN;JPAMH(@
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MWL+X6LKW4ES;O"(R%3#M,\J.&)XVESZYP* .JM+ZWOA,;=RXAF:%SM(&]>&
MSUP>,CWJQ5'1]/&E:1:V6_S&B0!Y#UD<\LQ]RQ)_&KU !1110 4444 %%%%
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MDJ$$2 PB4,><CC/YCWH Z:BN6;QS9BWDN4L+Z2"*U%W*ZJGR(6=0,%LEB4/
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M4J<# &%4# &-H(P>:GA\,:?;ZFNHP^<ETLK2EP_+ QJA1L]5PBG![C.:V:*
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %! F8# 2(  A$! Q$!_\0
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M =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\
M"M>B@#(_X17P[_T =+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\
MT =+_P# ./\ PH_X17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH
M_P"$5\._] '2_P#P#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =
M+_\  ./_  K7HH R/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#
M(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T
M=+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X
M17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P
M#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R
M/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\
MP#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T =+_\ X_\*/\ A%?#
MO_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X17P[_P! '2__  #C
M_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P#C_PK7HH R/^$5\.
M_P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R/^$5\._] '2__ ./
M_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\
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M7_C-_P B?:?]?Z?^BY** .N\*_\ (H:)_P!>$'_HM:UZR/"O_(H:)_UX0?\
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M*U3_ ,!O_KT :]%9']O#_H%:I_X#?_7H_MX?] K5/_ ;_P"O0!KT5D?V\/\
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M_KT :]%9']O#_H%:I_X#?_7H_MX?] K5/_ ;_P"O0!KT5D?V\/\ H%:I_P"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:-:BBBH*"BBB@#SKXS?\B?:?]?Z?^BY**/C-_P B?:?]?Z?^BY** .N\*_\
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M>6^L%N9KES&K<EF&U &4 #N":Z?P%]@NO"]MJMGIEII\E\N^XCM$"QF125)
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M/]OO_2M&B@#.-_>@G_B3W)Z_\M8N><?W_3FC[?>Y_P"0/<_]_8O7']_TY_\
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M _*C^Q-)SG^S+//7_4+ZY]/7GZT 7LCU%&1ZBJ(T32001IEGQ_TP7USZ>O-
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M4 7LCU%&1ZBJ)T32223IEF<YS^X7N<GMZ@&C^Q-)SG^S+//7_4+ZY]/7GZT
M7LCU%&1ZBJ(T321C&F68QC'[A>,'([>I)H&AZ2N,:99C&,8@7C&<=O<_G0!>
MR/449'J*HC0])  &F68QC'[A>PP.WH<4?V'I.,?V99XZ?ZA?3'IZ<?2@"]D>
MHHR/451.AZ2<YTRS.<Y_<+SD8/;T %!T/26SG3+,YSG,"\YQGM[#\J +V1ZB
MC(]15$Z)I)))TRS.<Y_<+W.?3UYH_L32<Y_LRSSU_P!0OKGT]>?K0!>R/449
M'J*HC0])&,:99C&,8@7C!R.WJ30-#TE<8TRS&,8Q O&,X[>Y_.@"]D>HHR/4
M51&AZ2  -,L^.G[A?3'IZ<4?V'I.,?V99XZ?ZA?3'IZ<?2@"]D>HHR/451.A
MZ2<YTRS.<YS O.1@]O0#\J#H>DMG.F69SG.8%YSC/;V'Y4 7LCU%5-.P8II"
M>9)Y"?P.T?H!6'KEII]J\/D6%D"I9YAY"'(/ SQW<J?^ UI67AW3+6SAA>RM
MYG10#))"I9CG.2<>O-7:T;]R+WE;L:N1ZBJ>K1B;2+M-@D)B8A?4XR*:-#TD
M8QIEF,8QB!>,'([>I/YTUM!TDQE5TVT3C *P*"N 0,<=LFI3L[E-75C&M]:3
M4;MK5F++/<I) 3]WRP%./J<$UIWVCQRK']ES"^41RCD?NP1_+ Q4&G^&+*TG
MN/-MK>:$K&D(DC#$!4VDG(ZGFK_]AZ21C^S+/_OPOICT]./I6LYI2]PSC%M>
M\9_DQZ#;Z/ 9'F1)_)\QOO$OG!/XFK]_J@L;VP@,9=;F4HS#G9QP3^.!5/5]
M'TJ/3)Y1IMF"HW9\E?49[=P *J2Z7I]_'(\%C;Q^98F4;8EX9SD'IS]VA>]K
M+S!^[HC4NS;W^I16#M'(D:M+-&3GMA01^)/X51NDNX=>ME*J;1[GSA(O4-LV
M;3^?&/2G:7I.D7BSW8T^T822<?NAC'RGITZC.:36](L(--::WTVV#1L&.R%<
MXSGT]3FA.TN4&KKF-_(]11D>HKG+>WT6UM+5)[&S><R+",0)N)#E0QXX&03^
M)K5&AZ2N,:99C&,8@7C' [>Y_.LG%K<T33+V1ZBC(]15'^P]) P-,L\?]<%]
M,>GIQ]*#H>DD8.F6?_?A?3'IZ<4AE[(]11D>HJB=#TELYTRS.<YS O.<9[>P
M_*@Z'I)SG3+,YSG,"\Y.3V]A^5 %[(]166HN)_$#L74VMNH 7/(<KU_)B/PI
ME_8:/8VK7,FE6K@,,A8$SRP.>GKS^%,L-%TN1[BX.GVGSS$*OD+\H0X';U!;
MZFKC=)LEZNQ=U?:='NV.#LB+CZJ,_P!*I:#8.((=1O+I[BZEA5N3\J;@"<#Z
MD_GBK@T/21C&F6?&,?N%[9QV]S^="Z'I*@!=+L@!C $"\8&!V]"?SH4VH\H.
M-Y7+V1ZBLK2?^0CK/_7VO_HI*G_L/2<8_LRSQT_U"^F/3TX^E5=#AC@O-7BA
MC6.-;I0J(, #RDZ"H*-FBBB@ HHHH \Z^,W_ ")]I_U_I_Z+DHH^,W_(GVG_
M %_I_P"BY** .N\*_P#(H:)_UX0?^BUK7K(\*_\ (H:)_P!>$'_HM:UZ .7\
M3ZOX2T&Y@?7K>#S[H-L8V)F9]N,\JIZ CK5_PUK^AZ_IQDT&>.2VA;RRB1&/
MRSC(&T@$9!STYS7,_$ WQUO14T1=4_MIHI_*>S>%4\KY/,#>=\I.=N,<\&M3
MP'X73PWI,C,MZEU=E7FCO)UE>/:NT+N7@C@GCUH ZNBBB@ KB_%OB+2?#/BS
M0;[6;U+2V:VNXQ(RL06)A.. ?2NTKC_%&A:7X@\7:%9ZO8PWEN+6[<1RC(#
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M<A'Y[:W='\)Z!X?2X32=)M;1;D!9A&G^L S@'U')_.LH_"[P.3G_ (1G3_\
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ME9+>23>^Z4R<C@)P=_3Z^];JMK2QA5MK#@8&;A_;&?D^M1))+0J+;>II@ #
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MM4;5 ]!BHA;XO6N=W6,1[<>A)S^M35I.?,DNQ$8V;84445F6%%%% !63I/\
MR$M9_P"OM?\ T4E:U9.D_P#(2UG_ *^U_P#124 :U%%% !1110!YU\9O^1/M
M/^O]/_1<E%'QF_Y$^T_Z_P!/_1<E% '7>%?^10T3_KP@_P#1:UKUD>%?^10T
M3_KP@_\ 1:UKT %%%% !117%1^,+Y;.22XACAO)I!':VDUO)$?FF$:L68_.!
MN4G:!UH [6N?U#_D>]#_ .O.\_G#5K0]3GO_ +?;W:Q"YL;DV\C19"/\JN&
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MZAY_Z:"@">BH/MMH?^7J'_OX*/MMI_S]0_\ ?P>F?Y4 3T5!]MM!_P O4/\
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M"6L_]?:_^BDJ_P#;;3_GZA_[^#TS_*L_1G5[_6&1@RFZ4@@Y!_=)0!KT444
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MT#2M.&,6%J,8Q^Y7C'3M[FK=% %0:5IPQBPM1C&/W*^F/3TH_LK3L8^P6O\
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MW*\YZ]O85;HH J'2]/.<V%KS_P!,5]<^GKS1_9>GY_X\+7_OROKGT]>:MT4
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ME5+N06QEB !A2<GTIF@^(=-\1V"W>GW"/P/,BW O$3V8 \'^?:@"I]C\6_\
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M "HKE9GM9EMW5)RA$;L,A6QP2/K5:^U>ST^WN)990Q@VAXH_F?<YPB[>N6)
M'K7!-=_\)?KLKQ7%[&F/LT'DDK)IDZYW":,,5D1_[_(P-O'6@">QNX=*UO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% &=K/_'FG_70?R-%%% '
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F8# 2(  A$! Q$!_\0
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M =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\
M"M>B@#(_X17P[_T =+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\
MT =+_P# ./\ PH_X17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH
M_P"$5\._] '2_P#P#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =
M+_\  ./_  K7HH R/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#
M(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T
M=+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X
M17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P
M#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R
M/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\
MP#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T =+_\ X_\*/\ A%?#
MO_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X17P[_P! '2__  #C
M_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P#C_PK7HH R/^$5\.
M_P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R/^$5\._] '2__ ./
M_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\
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M8QSN1MWR*3\H W#"GDXZBMB;P-H,^D:AI<EM(;2_O#?7"^<V6E+!L@YR.5'
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M9WVKVAN7D.+F*)!M=\<,1Z^U4O!WCV&?XC6VI/KK31Z_<W%L^G,[$6B@@6Y
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M33]*VP76M[Y)9)78J9& &>^!@=!0!B#XA:KI$]RGB"PLV7^QFU>W^P.Q.U<
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M 4444 %%%% !1110 4444 %%%% 'G?QE_P"10M/^O]/_ $7)11\9?^10M/\
MK_3_ -%R44 =;X5_Y%#1/^O"#_T6M:]9'A7_ )%#1/\ KP@_]%K6O0 4444
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M1_R$-9_Z^Q_Z*2M:LG2/^0AK/_7V/_124 :U%%% !1110!YW\9?^10M/^O\
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MT_Z_T_\ 1<E%'QE_Y%"T_P"O]/\ T7)10!UOA7_D4-$_Z\(/_1:UKUD>%?\
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M4-K%GRXE"C/6IZ**3=]64M HHHI %%%% !1110 4444 %%%% !1110 4444
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MDHH^,O\ R*%I_P!?Z?\ HN2B@#K?"O\ R*&B?]>$'_HM:UZR/"O_ "*&B?\
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M17JRQ;BWOR<#/IC\:=_9<,V&O";B;^^25P/8 \5>HHYGT#E1F)I#1L56_NA
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MC 51@"G445!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+--;7$%]$9TF@50%>4KC:PW% 3]\  @XR/0M,LO[-TJTL?.>;[/"D7F/U?:
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M?&7_ )%"T_Z_T_\ 1<E% '6^%?\ D4-$_P"O"#_T6M:]9'A7_D4-$_Z\(/\
MT6M:] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!YW\9?^10M/\ K_3_ -%R44?&7_D4+3_K_3_T
M7)10!XW8^)M?BT^VCCUS4DC2)555NY %  P ,U8_X2KQ%_T']4_\#)/\:**
M#_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\
M R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T'
M]4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*
MO$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_
M !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\
M#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_
M $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_
MX2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\
M:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']
M4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ
M%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:**
M#_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\
M R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T'
M]4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*
MO$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_
M !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\
M#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_
M $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_
MX2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\
M:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']
M4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ
M%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:**
M#_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\
M R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T'
M]4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*
MO$7_ $']4_\  R3_ !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_
M !H_X2KQ%_T']4_\#)/\:** #_A*O$7_ $']4_\  R3_ !H_X2KQ%_T']4_\
E#)/\:** ,GQ#K^LWNGQQW6K7\\8E#!9;EV .#S@GW-%%% '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
